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increasingly being used for both diagnostic coronary angiography
and percutaneous coronary intervention. Radial artery occlusion
is a complication of transradial catheterization that can lead to
permanent occlusion of the radial artery. Estimated incidence in
different studies is around 10%. Once radial artery is occluded, it
cannot be used for future catheterization and become inappro-
priate for bypass graft. Hand ischaemia due to radial artery oc-
clusion requiring medical or surgical attention is reported in 0.2%
of patients. So in our study we tried to assess incidence of radial
artery occlusion following transradial catheterization & also tried
to assess effect of placebo vs postprocedural intra arterial nitro-
glycerine on incidence of radial artery occlusion on day 1.
Methods: In our study we selected 430 patients who underwent
transradial catheterization. 226 patients were given post-
procedural 200ug nitroglycerine before removal of radial sheath
while 204 patient were given placebo. Next day all patients were
evaluated with duplex ultrasound for radial artery antegrade flow.
Results: Out of 430 patients, 144 had no antegrade flow in radial
artery. Incidence of radial artery occlusion on day 1was 33% in our
study.
Out of 226 patients who were given intra arterial nitroglycerine,
45 had no antegrade flow in radial artery.
While in placebo group out of 204 patients, 99 developed radial
artery occlusion. So, radial artery patency rate was significantly
higher (p value <0.001) in nitroglycerine group as compared to
placebo group.
Conclusion: Radial artery occlusion is usually a clinically silent
event due to good collateral from ulnar artery but Radial artery
occlusion cannot be ignored as it is having several disadvantages
for patient, cardiologist as well as for surgeon. Radial artery oc-
clusion rate can be minimized by this very simple intervention in
form of post procedural 200ug nitroglycerine before removal of
radial sheath.
Our experience with drug eluting balloons for
coronary interventions
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Background: Role of drug eluting balloons for in-stent re-stenosis
(ISR) and small vessel coronary artery disease was shown to be
promising. DEB alone was shown to be superior to drug eluting
stent in ISR and to BMS plus DEB in small vessel disease.
Aims: To present the immediate and short term outcome of our
experience with DEB.
Methods: We collected the data of all consecutive patients who
have undergone DEB at our centre in the last nine months. We
present their demographic profile, indications, procedural out-
comes and short term clinical outcomes.
Results: Nine patients (6 male & 3 female) underwent percuta-
neous interventionwith DEB at our centre in the last ninemonths.
Seven of them were for small vessel disease with a mean refer-
ence vessel diameter of 1.93±2.8 mm, and in two patient it was for
drug eluting stent ISR. Pre dilatation was done for all lesions
before DEB and cutting balloon was used for opening the ISR
before DEB. In all the seven patients with small vessel disease,
2mm balloons were used to dilate at or below the nominal pres-
sure and there good distal flow in all of them. Four of them were
paclitaxel eluting and four were sirolimus eluting balloons. As all
patients received a DES in another vessel they were all maintained
on oral dual anti-platelet therapy till the last follow up. The mean
follow up period was 148±63 days till which time there was no
major adverse cardiovascular events.
Conclusion: Drug eluting balloon in our experience has excellent
procedural and short term outcome for small vessel PCI and ISR.
Prevalence of CYP2C19 gene polymorphism in
patients with acute coronary syndrome
undergoing PCI
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Background: Clopidogrel is metabolized in liver to its active form
by cytochrome P450 enzyme. The production of this enzyme is
controlled by several genes including CYP2C19 gene. Two single
nucleotide polymorphisms (SNPS) in the CYP2C12 gene have
found to be significantly associated with clopidogrel metabolism.
Methods: We studied 100 consecutive patients undergoing PCI for
acute coronary syndrome for single nucleotide polymorphism in
CYP2C19 gene, by GAAP e X METHOD.
Results: Out of 100 patients, 22 patients (22%) were poor metab-
oliser, and 34 patients (34%) were intermediate metaboliser, and
44% were normal metaboliser. Nearly 22% of patients who are
poor metaboliser were given newer agents like ticagrelor or pra-
sugrel and in intermediate metabolisers, the dose of clopidogrel
was increased to 150 mg OD.
Conclusion: CYP2C19 gene polymorphism is common in south
Indian population and poor metabolisers are given newer agents
to prevent stent thrombosis and recurrent cardiac events.
Safety and efficacy of the Frontrunner XP Catheter
for recanalization of chronic total occlusion of the
femoropopliteal arteries
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Objective: The purpose of this study was to examine the safety
and efficacy of the Frontrunner XP CTO (chronic total occlusion)
catheter (Cordis Corporation) for recanalization of CTO of femo-
ropopliteal arteries.
Methods: A retrospective analysis of consecutive patients with
critical limb ischemia (CLI) who underwent femoropopliteal an-
gioplasty for TransAtlantic Inter-Society Consensus (TASC) class
D lesions between 2009 and 2011 was performed. Twenty-two
patients were enrolled with a mean age of 58.9 ± 11.5 years. Pa-
tients were enrolled with totally occluded arteries (mean occlu-
sion length, 18.0 ± 10.1 cm) that were treated with the Frontrunner
XP CTO catheter. All lesions were complex (TASC D) and 86.4% of
the lesions weremildly calcified. A Frontrunner catheter was used
to treat 22 CTOs after guidewire failure.
Results: Twenty-two of the 33 cases (66.7%) had failed previous
attempts of percutaneous intervention with conventional guide-
wire. The Frontrunner catheter was used to treat 22 CTOs after
guidewire failure. The Frontrunner catheter successfully facili-
tated the placement of a guidewire into the distal true lumen in 21
cases (95.5%). Thrombolysis in Myocardial Infarction 3 flow was
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achieved in all target vessels after further balloon angioplasty or
stenting.
Conclusions: TheFrontrunnerXPCTOcatheter is safe andeffective
for successful recanalization of CTO of femoropopliteal arteries
and it should be an alternative method after guidewire failure.
Effect of contrast media in patients with CKD
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Background: To assess the influence of contrast media over the
renal function in patients of CKD.
Methods: Retrospectively 50 patients have been studied. Data
regarding patient risk factors, LV function was collected. Renal
function (creatinine clearance) pre, post procedure was assessed
with Cockraft-Gault formula. All patients were given adequate pre
and post procedure hydration. High dose atorvastatin (80mg) on the
day of the procedure. Patients were monitored for 5 days following
the procedure with daily Biochemical analysis (Bl.Urea, S.crea-
tinine,Na+,K+,Cl- ).Also strict vigilance was maintained for develop-
ment of local complications like hematoma , pseudo aneurysm etc.
Results: Out of 50 patients, 31 were diabetics, all were hyperten-
sives, 14 persons were smokers.>50% of the patients had hyper-
tension. Most common procedure was PTCA. 10 patients were
already on renal replacement therapy. One of the patients studied
developed significant renal dysfunction following the procedure
requiring dialysis, later expired (underwent irregular dialysis
sessions & follow up). Another patient who used to get recurrent
episodes of accelerated hypertension, LVF, died of the same dur-
ing follow-up after PTCA. In the rest of the patients there was no
worsening of renal function.
Conclusion: Percutaneous interventions requiring contrast expo-
sure are safe even in patients with renal derangement, provided
adequate protective measures are taken.
Microalbuminuria as a risk factor for contrast-
induced nephropathy
P. Mittal, C.M. Varma, R. Thakur, R.P.S. Bhardwaz, M. Ahmad,
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Background: CIN is one of the most important causes of acute
renal failure in hospitalized patients with the incremental use of
contrast media. We aimed to investigate whether micro-
albuminuria may act as a risk factor for CIN in patients with CAD
undergoing percutaneous intervention.
Methods: 70 hospitalized patients (37 men, 33 women) with CAD,
microalbuminuria and estimated glomerular filtration rate (eGFR)
of >60mL/min/1.73m2, whowere exposed to contrastmedia were
compared prospectively with matched cohart of 70 patients (36
men, 34 women) without microalbuminuria. Microalbuminuria
defined as 30-300 mg albumin/24 urine. All patients received
prophylaxis against CIN with 0.9% intravenous saline. CIN is
defined as either a 25% higher increase in serum creatinine (sCr)
from the baseline levels or a 0.5 mg/dL increase in sCr at 72 h after
contrast media exposure.
Results: The incidence of CIN was significantly higher than in
matched patients without microalbuminuria (17.1% vs 7.1%,
p<0.05). Correlation is more significant in patients with higher
volume (>150ml) of contrast use (32% vs 11.5% p-value <0.01).
Conclusion: Microalbuminuria may be a new risk factor for the
development of CIN in patients of CAD undergoing percutaneous
intervention especially in patients with expected high volume of
contrast use.
Experience of Left main (LM) percutaneous
transluminal coronary angioplasty (PTCA) at JJ
Hospital
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Background: LM PTCA was an indication for CABG. But, LM PTCA
is becoming upcoming method for the same. We present experi-
ence of LM PTCA at our institute.
Methods: Patients presenting with ACS or CSA were subjected to
CAG. Those having LM significant (>50%) lesion were included in
study. Patients were explained the options for revascularization
and consent were taken from those opting PTCA. Patients were
loaded with 60 mg prasugrel or 600 mg clopidogrel. All patients
were stented with DES (Evorolimus/Zotarolimus). Pre and post
procedure intravascular ultrasound (IVUS) was used. Injectable
heparin was used intra and postoperatively. All patients were
given aspirin and prasugrel/clopidogrel.
Patients were followed up by regular outpatient visit. Those
having chest pain were subjected to CAG.
Results: Total 46 patients underwent LM PTCA. 26(56.52%) were
males and 20(43.47%) were females. Mean age was 55 years.
38(82.60%) had HTN, 5(10.86%) were DM. 18(39.13%) were smoking.
28(60.86%) had dyslipidemia.
2 (4.34%) had AMI. 3(6.42%) had NSTEMI. 6(13.06%) had unstable
angina. 35(76.08%) presented with CSA. Mean LVEF was 53.86%
24 (57.17%) patients had only LM lesion. Out of these, 5(10.86%)
had ostial LM lesion, 12(26.08%) had mid LM lesion, 7(15.21%) had
distal LM lesion. 9(19.56%) had LM plus ostial LAD lesion. 6(13.04%)
had LM plus non ostial LAD lesion. 3(6.42%) had LM plus LCX le-
sions. 3(6.42%) had LM plus RCA lesion. 1(2.17%) had LM plus
multivessel lesions.
3(6.52%) died during immediate postoperative period. Out of
them, 1 presented with AMI in poor general condition, second had
contrast induced nephropathy and third had multiple comorbid-
ities who refused CABG. 3(6.52%) lost follow up, 3(6.42%) died out
of hospital with unknown etiology. We performed CAG at mean 1
year follow up in 25(80.43%) patients, out of them 5(20%) had chest
pain and among them 2 had de novo lesions in other vessel. All
other patients had normal coronaries.
Conclusion: LM PTCA is an upcoming alternative for CABG and
has good success.
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